[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1806 Introduced in Senate (IS)]







104th CONGRESS
  2d Session
                                S. 1806

 To amend the Federal Food, Drug, and Cosmetic Act to clarify that any 
    dietary supplement that claims to produce euphoria, heightened 
 awareness or similar mental or psychological effects shall be treated 
            as a drug under the Act, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 23, 1996

   Mr. D'Amato (for himself, Mr. Dodd, and Mr. Frist) introduced the 
 following bill; which was read twice and referred to the Committee on 
                       Labor and Human Resources

_______________________________________________________________________

                                 A BILL


 
 To amend the Federal Food, Drug, and Cosmetic Act to clarify that any 
    dietary supplement that claims to produce euphoria, heightened 
 awareness or similar mental or psychological effects shall be treated 
            as a drug under the Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DEFINITION OF DRUG.

    Section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 321(g)(1)) is amended by adding at the end thereof the following 
new sentence: ``Notwithstanding the preceding sentence, a dietary 
supplement shall be considered a drug under clause (C) if the label or 
labeling of such drug claims or implies that the dietary supplement 
produces euphoria, heightened awareness, or similar mental or 
psychological effects.''.
                                 <all>